All Posts

“Quality Is Slowing Us Down.” (It Doesn’t Have To.) I hear this from biotech leadership more often than I’d like. And honestly—I get it. When you’re burning runway and racing toward IND-enabling studies, your next funding will milestone, or your first GMP batch, quality systems can feel like bureaucratic friction: one more approval layer standing between you and the thing that actually matters. But after 13 years working in FDA GMP- and EPA GLP-regulated environments, I’ve co

There’s a misconception that quietly persists in quality circles: that an FDA inspection is fundamentally adversarial. That the investigator walking through your door is there to catch you, expose you, shut you down. That’s not quite right — and misunderstanding the dynamic can actually make you less prepared. FDA investigators are trained professionals executing a systematic process. Their job is to verify that what you say you do is what you actually do. The gap between tho

How product stage plans build the quality foundation your pipeline actually needs Most biotech and pharma companies don't fail at science. They fail at the handoffs. GLP to GMP. Research to development. Development to manufacturing. Each stage transition is a minefield of undocumented processes, unvalidated methods, and supplier relationships that were never properly qualified. And yet, quality infrastructure is almost always the last thing companies think about — and the f

You Don’t Pass an FDA Inspection the Week Before. You Pass It Every Day. There’s a persistent myth in life sciences that inspection readiness is something you achieve right before an audit — a flurry of binder updates, a few mock walkthrough sessions, maybe a late Friday afternoon spent closing out that deviation from Q2. I’ve spent over a decade helping companies prepare for FDA inspections, and I can tell you: that approach doesn’t work. And more importantly, it doesn’t hav

There’s a building in San Francisco’s Mission District that I think about sometimes. From the outside, it looks fine. Functional, even. But step inside and you’ll find hallways that lead nowhere, stairwells that don’t connect floors logically, rooms that were clearly added as afterthoughts — a storage closet awkwardly wedged between what used to be two offices, a bathroom accessible only by walking through someone else’s workspace. Nobody planned it that way. It just… grew. I

The quality management system documentation looks pristine. Every SOP is numbered, approved, and filed correctly. The audit reports came back clean. Your contract manufacturing organization (CMO) checked every box during the selection process. Then the first batch deviation lands in your inbox, and suddenly you’re navigating a quality incident at a facility you don’t control, with a team you didn’t hire, following processes you didn’t write. Welcome to one of biotech’s most u

When Your CMO’s Quality System Looks Great on Paper (But Reality Hits Differently) You’ve done everything right. You’ve vetted your Contract Manufacturing Organization, reviewed their quality management system documentation, confirmed their certifications, and signed the contract. Their QMS looks polished, comprehensive, and FDA-ready. Then you get the first batch deviation report. The manufacturing team missed a critical in-process check. The deviation investigation took thr